Harvard Bioscience, Inc.
Harvard Bioscience, Inc.（HBIO）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
hbio · 股价预测 · 5 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 5 位华尔街分析师
Buy
5 位分析师
共识
评级分布
12 个月目标价
High
$6.00
Consensus
$6.00
-0.2% upside
Low
$6.00
Median: $6 · Last Close: $6.01
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $6.31 | ↑ 5.00% |
1-day model range: $6.25–$6.37. Peak: $6.37 (+5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · HBIO · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-16 | Benchmark | Maintains | Speculative Buy→Speculative Buy |
| 2026-03-13 | Benchmark | Maintains | Speculative Buy→Speculative Buy |
| 2025-09-10 | Benchmark | Maintains | Speculative Buy→Speculative Buy |
| 2025-05-13 | Benchmark | Maintains | Speculative Buy→Speculative Buy |
| 2025-04-09 | Keybanc | Downgrade ↓ | Overweight→Sector Weight |
| 2025-04-08 | Keybanc | Downgrade ↓ | Overweight→Sector Weight |
| 2025-03-24 | Benchmark | Maintains | Speculative Buy→Speculative Buy |
| 2023-06-22 | Benchmark | Maintains | Speculative Buy→Speculative Buy |
| 2023-04-26 | Keybanc | Maintains | Overweight→Overweight |
| 2023-04-26 | Benchmark | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Harvard Bioscience, Inc. (HBIO) stock. Of the recent 19 rating actions, 1 were upgrades and 2 were downgrades. 5 analysts currently cover HBIO.
分析师推荐趋势
HBIO analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 2 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$94M
↑ 5.8% YoY
Revenue Next Year
$86M
↓ 8.4% YoY
EPS This Year
$0.45
EPS Next Year
$0.30
↓ 33.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast HBIO EPS of $0.45 for the current fiscal year, based on estimates from 1 analysts. The HBIO revenue forecast is $94M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
HBIO 股价预测由两类独立数据源支撑：来自 5 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。HBIO 的共识目标价为 $6.00（-0.2% 上行空间），分析师共识为 Buy。
HBIO 的短期预测（明日）为 $6.31（+5.00%）。
Harvard Bioscience, Inc. 在 NASDAQ 上市，代码 HBIO。HBIO 在 2027 年的整体展望偏积极，在覆盖分析师中约 80% 对应 Buy 共识。
常见问题
HBIO 预测 · 8 个问题根据 5 位华尔街分析师，HBIO 的 12 个月平均目标价为 $6.00，最高 $6.00、最低 $6.00。若有图表，中位目标价可在上方查看。相对当前价 $6.01，隐含约 -0.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.